Full Text View
Tabular View
Study Results
Related Studies
Use of Fenofibrate for Primary Biliary Cirrhosis
This study has been completed.
Study NCT00575042   Information provided by University of Florida

First Received on December 13, 2007.   Last Updated on December 2, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Primary Biliary Cirrhosis
Additional conditions recognized in this trial
Fibrosis
Liver Cirrhosis
Liver Cirrhosis, Biliary
More general conditions related to this trial
Bile Duct Diseases
Biliary Tract Diseases
Cholestasis
Cholestasis, Intrahepatic
Digestive System Diseases
Liver Diseases
Pathologic Processes
Additional drug interventions recognized in this trial
Fenofibrate
More general drug interventions related to this trial
Antimetabolites
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Florida
The PBCers Organization
Shionogi Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services